Madrigal Pharmaceuticals (MDGL) EPS (Diluted) Growth (3y) (2013 - 2026)
Madrigal Pharmaceuticals (MDGL) EPS (Diluted) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.01% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.90% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 61.64% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 36.83% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.99% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -36.81% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 36.39% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 67.51% |
| 10 | Madrigal Pharmaceuticals | 14.79 Bn | 13.95 Bn | - | 25.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.20% |
| Mar 31, 2026 | 9.07% |
| Dec 31, 2025 | -15.21% |
| Sep 30, 2025 | -1.35% |
| Jun 30, 2025 | 22.81% |
| Mar 31, 2025 | 0.48% |
| Dec 31, 2024 | 10.56% |
| Sep 30, 2024 | -9.06% |
| Jun 30, 2024 | -23.13% |
| Mar 31, 2024 | -32.27% |
| Dec 31, 2023 | 21.47% |
| Sep 30, 2023 | 47.05% |
| Jun 30, 2023 | 46.44% |
| Mar 31, 2023 | 42.69% |
| Dec 31, 2022 | 55.81% |
| Sep 30, 2022 | 29.19% |
| Jun 30, 2022 | 30.37% |
| Mar 31, 2022 | 28.97% |
| Dec 31, 2021 | 50.04% |
| Sep 30, 2021 | 10.52% |